)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
Genovis
Genovis (GENO) investor relations material
Genovis Q1 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2026 earnings summary28 Apr, 2026
Executive summary
Net sales reached SEK 33,506 thousand, up 4% year-over-year, or 17% when adjusted for currency effects.
EBITDA improved to SEK 9,510 thousand, with a margin of 28.4%, reflecting strong cost discipline.
Cash flow from operating activities was robust at SEK 16,511 thousand, reinforcing financial flexibility.
Product launches and strategic partnerships expanded the offering in genomics and ADC technologies.
Large pharma segment saw organic growth exceeding 30%, while biotech showed sequential recovery.
Financial highlights
Net sales: SEK 33,506 thousand (SEK 32,292 thousand Q1 2025), 4% reported growth, 17% currency-adjusted.
EBITDA: SEK 9,510 thousand (SEK 8,906 thousand), margin 28.4% (27.6%).
EBIT: SEK 5,777 thousand (SEK 6,391 thousand), margin 17.2% (19.8%).
Earnings per share: SEK 0.06 (SEK 0.05).
Cash flow from operating activities: SEK 16,511 thousand (SEK 10,652 thousand).
Outlook and guidance
Business opportunities and operational capacity assessed as good for 2026, despite macroeconomic and geopolitical uncertainties.
Continued advances expected in new product launches and sales.
Detail EndoS2 license milestone triggers
Explain service revenue project volatility
Discuss biotech segment recovery trajectory
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Genovis
- Strong Q4 sales growth and robust margins, boosted by a major order and Sequrna AB acquisition.GENO
Q4 202512 Feb 2026 - Sales dipped in Q3, but pharma growth, Sequrna acquisition, and a major order boost outlook.GENOQ3 20257 Nov 2025
- Enzyme business delivered strong growth and profitability, expanding strategically into genomics.GENOQ2 202512 Aug 2025
- Record enzyme sales and profitability in Q3 2024, fueled by strategic focus and innovation.GENOQ3 202413 Jun 2025
- Flat Q2 sales, lower H1 profit, strategic antibody divestment, and SEQURNA investment.GENOQ2 202413 Jun 2025
- Record enzyme business growth and strong profit despite currency headwinds.GENOQ1 20256 Jun 2025
- Enzyme business sales surged 21% in Q4, with robust margins and a strengthened cash position.GENOQ4 20245 Jun 2025
Next Genovis earnings date
Q2 202623 Jul, 2026
Genovis
Next Genovis earnings date
Q2 202623 Jul, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage